https://www.yiliao.com/index.php?action=history&feed=atom&title=CHEK2
CHEK2 - 版本历史
2026-04-08T16:34:15Z
本wiki的该页面的版本历史
MediaWiki 1.35.1
https://www.yiliao.com/index.php?title=CHEK2&diff=317417&oldid=prev
223.160.136.180：建立内容为“<div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff…”的新页面
2026-03-23T08:14:46Z
<p>建立内容为“<div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff…”的新页面</p>
<p><b>新页面</b></p><div><div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff; max-width: 1200px; margin: auto;"><br />
<br />
<div style="margin-bottom: 30px; border-bottom: 1.2px solid #e2e8f0; padding-bottom: 25px;"><br />
<p style="font-size: 1.1em; margin: 10px 0; color: #334155; text-align: justify;"><br />
<strong>[[CHEK2]]</strong>（Checkpoint Kinase 2）是一种关键的<strong>[[细胞周期检查点激酶]]</strong>，编码一种多功能的丝氨酸/苏氨酸激酶。作为[[DNA损伤反应]]([[DDR]])信号通路中的核心成员，CHEK2主要受到[[ATM]]激酶的激活，进而磷酸化[[p53]]、[[BRCA1]]和[[Cdc25C]]等下游效应因子。它被视为基因组稳定性的“二级守门员”，负责调节细胞周期停滞、DNA修复及细胞凋亡。临床上，<strong>[[CHEK2生殖系突变]]</strong>被公认为多种癌症（尤其是乳腺癌、结直肠癌和前列腺癌）的<strong>[[中等外显率]]</strong>易感基因，其突变状态正日益成为肿瘤精准筛查与[[合成致死]]治疗探索的重要指标。<br />
</p><br />
</div><br />
<br />
<div class="medical-infobox mw-collapsible" style="width: 320px; margin: 0 auto 35px auto; border: 1.2px solid #bae6fd; border-radius: 12px; background-color: #ffffff; box-shadow: 0 8px 20px rgba(0,0,0,0.05); overflow: hidden;"><br />
<br />
<div style="padding: 15px; color: #1e40af; background: linear-gradient(135deg, #f0f9ff 0%, #bae6fd 100%); text-align: center; cursor: pointer;"><br />
<div style="font-size: 1.2em; font-weight: bold; letter-spacing: 1.2px;">CHEK2 (Chk2)</div><br />
<div style="font-size: 0.7em; opacity: 0.85; margin-top: 4px; white-space: nowrap;">Genome Guardian Kinase · 核心参数</div><br />
</div><br />
<br />
<div class="mw-collapsible-content"><br />
<div style="padding: 25px; text-align: center; background-color: #f8fafc;"><br />
<div style="display: inline-block; background: #ffffff; border: 1px solid #e2e8f0; border-radius: 12px; padding: 15px; box-shadow: 0 4px 10px rgba(0,0,0,0.04);"><br />
<div style="width: 140px; height: 90px; background-color: #f1f5f9; display: flex; align-items: center; justify-content: center; color: #94a3b8; font-size: 0.8em; padding: 10px; text-align: center; border-radius: 8px;">CHEK2 Protein Structure:<br>FHA & Kinase Domains</div><br />
</div><br />
<div style="font-size: 0.8em; color: #64748b; margin-top: 12px; font-weight: 600;">染色体定位：22q12.1</div><br />
</div><br />
<br />
<table style="width: 100%; border-spacing: 0; border-collapse: collapse; font-size: 0.85em;"><br />
<tr><br />
<th style="text-align: left; padding: 8px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0; width: 45%;">[[Entrez]] ID</th><br />
<td style="padding: 8px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">11200</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 8px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">[[HGNC]] 符号</th><br />
<td style="padding: 8px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">CHEK2</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 8px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">[[UniProt]]</th><br />
<td style="padding: 8px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">O96017</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 8px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">分子量</th><br />
<td style="padding: 8px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">~61 kDa</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 8px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">蛋白功能</th><br />
<td style="padding: 8px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">DDR/细胞周期调控</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 8px 12px; background-color: #f1f5f9; color: #475569;">突变类型</th><br />
<td style="padding: 8px 12px; color: #1e40af; font-weight: bold;">致病性生殖系突变</td><br />
</tr><br />
</table><br />
</div><br />
</div><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">分子机制：DDR 通路的接力者</h2><br />
<p style="margin: 15px 0; text-align: justify;"><br />
CHEK2 的功能是作为 DNA 双链断裂（DSBs）信号转导的放大器，其分子生物学路径如下：<br />
</p><br />
<ul style="padding-left: 25px; color: #334155;"><br />
<li style="margin-bottom: 12px;"><strong>ATM 介导的激活：</strong> 当 DNA 发生双链断裂时，[[ATM]] 激酶迅速被招募至损伤位点，并将 CHEK2 的 Thr68 位点磷酸化，引发其二聚化及自磷酸化激活。</li><br />
<li style="margin-bottom: 12px;"><strong>G2/M 停滞控制：</strong> 活化的 CHEK2 磷酸化 [[Cdc25C]] 磷酸酶，导致其被排除在细胞核外，从而抑制 [[Cyclin B1/CDK1]] 复合物的活性，使细胞周期停滞在 G2/M 期以进行修复。</li><br />
<li style="margin-bottom: 12px;"><strong>p53 依赖型凋亡：</strong> 如果损伤无法修复，CHEK2 通过磷酸化 [[p53]] 的 Ser20 位点增强其蛋白稳定性，触发下游促凋亡基因的表达，启动“受损细胞清除”程序。</li><br />
</ul><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">肿瘤易感性与临床关联</h2><br />
<div style="overflow-x: auto; margin: 30px auto; width: 95%;"><br />
<table style="width: 100%; border-collapse: collapse; border: 1.2px solid #cbd5e1; font-size: 0.9em; text-align: left;"><br />
<tr style="background-color: #f8fafc; border-bottom: 2px solid #0f172a;"><br />
<th style="padding: 12px; border: 1px solid #cbd5e1; color: #0f172a; width: 30%;">相关癌种</th><br />
<th style="padding: 12px; border: 1px solid #cbd5e1; color: #475569;">风险评估 (Relative Risk)</th><br />
<th style="padding: 12px; border: 1px solid #cbd5e1; color: #1e40af;">关键致病突变示例</th><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">[[乳腺癌]]</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">中等风险（约 2-3 倍风险）；累积终生风险约 20-30%。</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">[[c.1100delC]] (截短突变)</td><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">[[结直肠癌]]</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">约 1.5-2 倍风险；多见于非息肉病性家族聚集。</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">I157T (错义突变)</td><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">[[前列腺癌]]</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">增加致死性前列腺癌风险，尤其在年轻患者中。</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">生殖系截短变异</td><br />
</tr><br />
</table><br />
</div><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">临床干预与精准策略</h2><br />
<ul style="padding-left: 25px; color: #334155;"><br />
<li style="margin-bottom: 12px;"><strong>筛查共识：</strong> 对于携带 CHEK2 致病变异的乳腺癌高风险女性，[[NCCN指南]] 建议从 40 岁（或早于家族最早发病年龄 10 年）开始每年进行一次乳腺 MRI 筛查。</li><br />
<li style="margin-bottom: 12px;"><strong>合成致死机会：</strong> 类似于 BRCA 突变，CHEK2 缺失可导致同源重组修复（HR）受损。临床正在探索将 [[PARP抑制剂]]（如奥拉帕利）用于治疗 CHEK2 缺失的晚期实体瘤。</li><br />
<li style="margin-bottom: 12px;"><strong>家族遗传咨询：</strong> 由于 CHEK2 呈现常染色体显性遗传，建议对一级亲属进行级联检测，尤其是存在早发性癌症史的家族。</li><br />
</ul><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">关键相关概念</h2><br />
<div style="background-color: #f8fafc; border: 1px solid #e2e8f0; border-radius: 8px; padding: 15px; margin: 20px 0;"><br />
<ul style="margin: 0; padding-left: 20px; color: #334155; columns: 2;"><br />
<li style="margin-bottom: 8px;">[[ATM/ATR信号通路]]</li><br />
<li style="margin-bottom: 8px;">[[c.1100delC]]</li><br />
<li style="margin-bottom: 8px;">[[Li-Fraumeni-like综合征]]</li><br />
<li style="margin-bottom: 8px;">[[中等外显率基因]]</li><br />
<li style="margin-bottom: 8px;">[[PARP抑制剂]]</li><br />
<li style="margin-bottom: 8px;">[[同源重组修复缺陷(HRD)]]</li><br />
</ul><br />
</div><br />
<br />
<div style="font-size: 0.92em; line-height: 1.6; color: #1e293b; margin-top: 50px; border-top: 2.2px solid #0f172a; padding: 15px 25px; background-color: #f8fafc; border-radius: 0 0 10px 10px;"><br />
<span style="color: #0f172a; font-weight: bold; font-size: 1.05em; display: inline-block; margin-bottom: 15px;">学术参考文献与权威点评</span><br />
<br />
<p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"><br />
[1] <strong>Dorling L, et al. (2021).</strong> <em>Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women.</em> <strong>[[The New England Journal of Medicine]]</strong>.<br><br />
<span style="color: #475569;">[权威点评]：该项大规模人群研究明确了 CHEK2 作为乳腺癌中等外显率基因的地位，为临床多基因面板检测（MGPT）提供了基石证据。</span><br />
</p><br />
<br />
<p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"><br />
[2] <strong>Stolarova L, et al. (2023).</strong> <em>CHEK2 Germline Variants in Cancer Predisposition: Risks and Clinical Implications.</em> <strong>[[Journal of Clinical Oncology]]</strong>. [Academic Review]<br><br />
<span style="color: #475569;">[学术点评]：综述系统阐述了 CHEK2 不同突变位点对表型的影响差异，强调了基于变异类型的个体化风险评估的重要性。</span><br />
</p><br />
</div><br />
<br />
<div style="margin: 40px 0; border: 1px solid #e2e8f0; border-radius: 8px; overflow: hidden; font-size: 0.9em;"><br />
<div style="background-color: #eff6ff; color: #1e40af; padding: 8px 15px; font-weight: bold; text-align: center; border-bottom: 1px solid #dbeafe;"><br />
CHEK2 基因组健康 · 知识图谱<br />
</div><br />
<table style="width: 100%; border-collapse: collapse; background-color: #ffffff;"><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 90px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle;">上游激活</td><br />
<td style="padding: 10px 15px; color: #334155;">[[ATM]]•[[DNA双链断裂]]•[[MRE11/RAD50/NBN复合物]]</td><br />
</tr><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 90px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle;">下游底物</td><br />
<td style="padding: 10px 15px; color: #334155;">[[p53]]•[[Cdc25C]]•[[BRCA1]]•[[E2F1]]•[[PML]]</td><br />
</tr><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 90px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle;">临床应用</td><br />
<td style="padding: 10px 15px; color: #334155;">[[奥拉帕利]]•[[乳腺MRI筛查]]•[[多基因风险评估]]</td><br />
</tr><br />
<tr><br />
<td style="width: 90px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle;">研究热点</td><br />
<td style="padding: 10px 15px; color: #334155;">[[错义突变功能鉴定]]•[[CHEK2与PARPi耐药]]•[[非乳腺癌种的致病力分析]]</td><br />
</tr><br />
</table><br />
</div><br />
<br />
</div></div>
223.160.136.180